Trexquant Investment »

Enliven Therapeutics shares owned by Trexquant Investment

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Trexquant Investment from 13F filings

Historical chart of Trexquant Investment investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Trexquant Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Trexquant Investment

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.1M 78k 39.20
2025-09-30 $1.0M 51k 20.47
2025-06-30 $512k 26k 20.06

More positions owned by Trexquant Investment

NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Micron Technology Call Option (MU)
Amazon Call Option (AMZN)
Tesla Motors Put Option (TSLA)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Citigroup Com New Put Option (C)
Palantir Technologies Cl A Put Option (PLTR)
Pepsi (PEP)
Accenture Plc Ireland Shs Class A Call Option (ACN)
Alphabet Cap Stk Cl C Call Option (GOOG)
Chipotle Mexican Grill (CMG)
Eli Lilly & Co. (LLY)

View all positions for Trexquant Investment

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
BlackRock
Polar Capital Holdings
Commodore Capital
Vestal Point Capital
Vanguard Group
Citadel Advisors
Fairmount Funds Management
VR Adviser
Novo A/S
Geode Capital Management
State Street Corporation
Logos Global Management
Pictet Asset Management Holding SA

View all funds holding Enliven Therapeutics